Cargando…
HRG-β1-driven ErbB3 signaling induces epithelial–mesenchymal transition in breast cancer cells
BACKGROUND: Heregulin (HRG; also known as neuregulin) is a ligand for ErbB3. One of its isotypes, HRG-β1, binds to ErbB3 and forms heterodimers with other ErbB family members, thereby enhancing the proliferation and tumorigenesis of breast cancer cells. HRG stimulation may contribute to the progress...
Autores principales: | Kim, Jinkyoung, Jeong, Hoiseon, Lee, Youngseok, Kim, Chungyeul, Kim, Hankyeom, Kim, Aeree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750857/ https://www.ncbi.nlm.nih.gov/pubmed/23937725 http://dx.doi.org/10.1186/1471-2407-13-383 |
Ejemplares similares
-
Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit
por: Kim, Jinkyoung, et al.
Publicado: (2019) -
EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells
por: Kim, Jinkyoung, et al.
Publicado: (2016) -
Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
por: KIM, JINKYOUNG, et al.
Publicado: (2016) -
Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing
por: Choi, Yoojin, et al.
Publicado: (2017) -
Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition
por: NILSSON, GISELA M.A., et al.
Publicado: (2014)